Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.

Last updated: February 13, 2024
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

2/3

Condition

Warts

Treatment

Intralesional Acyclovir

Cryotherapy

Clinical Study ID

NCT06261684
MS-259-2023
  • Ages 18-70
  • All Genders

Study Summary

The goal of this prospective randomized controlled study is to study the safety and efficacy of intralesional acyclovir compared to cryotherapy in plantar warts. The main questions needed to be answered are:

  1. Is Intralesional acyclovir safe for plantar warts?

  2. Is Intralesional acyclovir more efficient in treating plantar warts compared to cryotherapy?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients aged 18 years or older, of both genders, with plantar warts

Exclusion

Exclusion Criteria:

  • Patients on systemic treatment for warts eg. Acitretin, Acyclovir
  • Hypersensitivity to Acyclovir
  • Previous treatment to the same wart during the last 3 months
  • Immunocompromised patients (as HIV, steroid intake, uncontrolled diabetes, etc.)
  • Pregnant and breastfeeding females
  • Cognitively impaired patients

Study Design

Total Participants: 92
Treatment Group(s): 2
Primary Treatment: Intralesional Acyclovir
Phase: 2/3
Study Start date:
October 01, 2023
Estimated Completion Date:
October 01, 2024

Connect with a study center

  • Cairo University Hospital

    Cairo,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.